Adma Biologics reported $102.78M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adma Biologics ADMA:US $ 102.78M 8.81M
Agile Therapeutics AGRX:US $ 10.68M 13.93M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
China Cord Blood CO:US 4.64B 125.51M
Dynavax Technologies DVAX:US $ 67.58M 15.8M
Kindred Biosciences KIN:US $ 79.77M 4.02M
Minerva Neurosciences NERV:US $ 28.08M 8.09M
Novavax NVAX:US $ 461.34M 284.23M
Omeros OMER:US $ -262697000 16.4M
Takeda 4502:JP Y 5323935M 24161M